Cargando…
HER2 expression should be routinely evaluated in DCIS to avoid under or overtreatment!
Autores principales: | Garg, Nidhi, Thorat, Mangesh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890724/ https://www.ncbi.nlm.nih.gov/pubmed/36733476 http://dx.doi.org/10.18632/oncoscience.572 |
Ejemplares similares
-
Multiclonality of ER expression in DCIS – Implications for clinical practice and future research
por: Thorat, Mangesh A.
Publicado: (2023) -
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
por: Hahn, Ezra, et al.
Publicado: (2023) -
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial
por: Thorat, Mangesh A., et al.
Publicado: (2021) -
Overtreatment of cruciate ligament injuries
por: Aspenberg, Per
Publicado: (2010) -
The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
por: Lewis, Gary. D., et al.
Publicado: (2021)